Breathlessness in cancer patients

European Journal of Cancer

Volumn 44, Issue 8, 2008, Pages 1116-1123

  Cachia, Elaine ^a   Ahmedzai, Sam Hjelmeland ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Breathlessness; Pallitive care

Indexed keywords

ANTHRACYCLINE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE; BRONCHODILATING AGENT; BUSULFAN; CISPLATIN; DEXAMETHASONE; DIAMORPHINE; DIAZEPAM; DIURETIC AGENT; FUROSEMIDE; GEMCITABINE; HYDROMORPHONE; IFOSFAMIDE; LORAZEPAM; MIDAZOLAM; MITOMYCIN; MORPHINE; NALOXONE; OPIATE; OXYCODONE; TRASTUZUMAB; VINDESINE;

AIRFLOW; ARTICLE; BRADYPNEA; BRONCHITIS; CANCER PATIENT; CONSTIPATION; COUGHING; DIAGNOSTIC TEST; DRUG DOSE TITRATION; DYSPNEA; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHANGITIS; OXYGEN THERAPY; PANIC; PATHOGENESIS; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RESPIRATION CONTROL; SEDATION; SIDE EFFECT; TERMINAL DISEASE;

EID: 43449130019     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.03.004     Document Type: Article

References (34)

1. D.J. Dudgeon L. Kristjanson J.A. Sloan M. Lertzman K. Clement Dyspnea in Cancer Patients: Prevalence and Associated Factors J Pain Symptom Manage 21 2001 02 95
2. C.A. Hauser M.R. Stockler M.H.N. Tattersall Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review Support Care Cancer 14 2006 999 1011
3. S.H. Ahmedzai Cough in cancer patients Pulm Pharmacol Therap 17 2004 415 423
4. M.A. Gillette R.M. Schwartzstein Mechanisms of dyspnoea S.H. Ahmedzai M. Muers Supportive Care in Respiratory Disease 2005 OUP Oxford 93 122 Chap 6
5. A. von Leupold B. Dahme Cortical substrates for the perception of dyspnoea Chest 128 2005 345 354
6. L.L.K. Rock R.M. Schwartzstein Mechanisms of dyspnea in chronic lung disease Curr Opin Support Palliat Care 1 2007 102 108
7. M.F. Piepoli A. Kaczmarek D.P. Francis C.L. Davies Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure Circulation. 114 2006 126 134
8. L.M. Parsons G. Egan M. Liotti S. Brannan Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air PNAS 4 2001 2041 2046
9. T. Manzke U. Guenther E.G. Ponimaskin M. Haller 5HT4A receptors avert opiods-induced breathing depression without loss of analgesia Science 2003 226 229
10. M.F. Muers Opioids for dyspnoea Thorax 57 2002 922 923
11. J. Yorke Dyspnoea and pain: an interesting analogy J Clin Nurs 2008 841 842
12. M.B. Reid J. Lannergren K. Westerblad Respiratory and limb muscle weakness induced by tumour necrosis factor – alpha Am J Respir Crit Care Med 166 2002 479 484
13. K. Tanaka T. Akewchi T. Okuyama Y. Nishiwaki Y. Uchitomi Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale Brit J Cancer 82 2000 800 805
14. V.A. Vora S.H. Ahmedzai Pulse oximetry in supportive and palliative care Support Care Cancer 12 2004 758 761
15. Hoskin P, Ahmedzai SH. Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai SH, Muers M, editors. Supportive Care in Respiratory Disease. Oxford: OUP; 2005. p. 463–86. Chap 30.
16. Kvale PA, Selecky PA, Prakash UBS. Palliative care in lung cancer. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007:132; 368S-403S.
17. L. Saffran D.E. Ost A.M. Fein M.J. Schiff Outpatient pleurodesis of malignant pleural effusions using a small-bore Pigtail catheter Chest 118 2000 417 421
18. S. Neragi-Miandoab Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology Support Care Cancer 2008
19. A.H. Navigante L.C.A. Cerchietti M.A. Castro M.A. Lutteral M.E. Cabalar Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnoea perception in patients with advanced cancer J Pain Symptom Manage 31 2006 38 47
20. A.-L. Jennings A.N. Davies J.P.T. Higgins J.S.R. Gibbs K.E. Broadley A systematic review of the use of opioids in the management of dyspnoea Thorax 57 2002 939 944
21. A.P. Abernethy D.C. Currow P. Frith B.S. Fazekas Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
22. P.J. Poole A.G. Vele P.N. Black The efect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1877 1880
23. K.E. Clemens E. Klaschik Symptomatic therapy of dyspnoea with strong opioids and its effect on ventilation in palliative care patients J Pain Symptom Manage 33 4 2007 473 481
24. A. Dahan A. Yassen R. Romberg E. Sarton Buprenorphine induces ceiling in respiratory depression but not in analgesia Brit J Anaesthesia 96 5 2006 627 632
25. T. Nishino T. Ide T. Sudo J. Sato Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnoea Am J Respir Crit Care Med 161 2000 1963 1967
26. S.H. Moosavi P.A. Binks R.W. Lansing G.P. Topulos R.B. Banzett R.M. Schwartzstein Effect of inhaled furosemide on air hunger induced in healthy humans Respiratory Physiology & Neurobiology 156 2007 1 8
27. H. Kohara H. Ueoka K. Aoe T. Maeda Effect of nebulized furosemide in terminally ill cancer patients with dyspnoea J Pain Symptom Manage 26 2003 962 967
28. S. Booth H. Anderson M. Swannick R. Wade The use of oxygen in the palliation of breathlessness Resp Med 98 2004 66 77
29. S.H. Ahmedzai E. Laude A. Robertson G. Troy V. Vora A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion Brit J Cancer 90 2004 366 371
30. R.M. Schwartzstein K. Lahive A. Pope S.E. Weinberger J.W. Weiss Cold facial stimulation reduces breathlessness induced in normal subjects Am Rev Respir Dis. 136 1 1987 58 61
31. R. MacLeod Psychosocial therapies S.H. Ahmedzai M. Muers Supportive Care in Respiratory Disease 2005 OUP Oxford 229 238 Chap 13
32. T. Morita A.H. Tsunoda S. Inoue S. Chihara Contributing factors to physical symptoms in terminally-ill cancer patients J Pain Symptom Manage 18 1999 338 346
33. T. Morita Y. Chinone M. Ikenaga M. Miyoshi Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan J Pain Symptom Manage 30 2005 308 319
34. M. Bennett V. Lucas M. Brennan A. Hughes Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care Palliat Med. 16 2002 369 374